Reports

Global Montelukast Sodium Competitive Landscape Professional Research Report 2025

Published:2025-05-10Pages:115Tables and Figures:130
Report ID:BJFL020307Report Format:Delivery:Within 72h

Full Report Selling Price
3500.00 USD
5250.00 USD
7000.00 USD
Buy NowContact Us
Competitor Data Selling Price
1000.00 USD
1500.00 USD
2000.00 USD
Buy NowContact Us
Important Clause:
Recently, our company has discovered that some websites have plagiarized, cited, and modified our original directories without authorization, seriously infringing on our company’s interests. In order to protect our intellectual property rights, we have decided not to publicly display specific enterprise lists, product segmentation types, and downstream applications. To view the complete content, please request a free sample.
*All report related content displayed on this website is original and our company has the sole copyright in DIReserch. Without prior permission from our company, it is not allowed to modify, reprint or cite in any way. Otherwise, our company reserves the right to pursue legal responsibility.
Research Scope
Table of Contents
Tables and Figures

Market Overview

According to DIResearch's in-depth investigation and research, the global Montelukast Sodium market size will reach 521.38 Million USD in 2025 and is projected to reach 1,119.17 Million USD by 2032, with a CAGR of 11.53% (2025-2032). Notably, the China Montelukast Sodium market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

Montelukast sodium is a medication that belongs to a class of drugs called leukotriene receptor antagonists. It is primarily used for the treatment and management of asthma and allergic rhinitis (hay fever) in both adults and children. Montelukast sodium works by blocking the action of leukotrienes, which are substances released in the body during an allergic reaction or asthma attack. By inhibiting leukotriene activity, it helps to reduce inflammation, constriction of airways, and other symptoms associated with asthma and allergies. This medication is available in tablet or chewable tablet form, and it is typically taken orally once a day. Montelukast sodium is often prescribed as a long-term preventive therapy to control asthma symptoms and improve overall respiratory function.

The major global  manufacturers of Montelukast Sodium include Morepen Laboratories, Mylan, TAPI, MSN Laboratories, Ultratech India, Aurobindo Pharma, Hetero Labs, Unimark Remedies, Jubilant Cadista, Aamorb Pharmaceuticals, Sudarshan Group, Ortin Laboratories, Adley Group, Vamsi Labs, Medopharm, Hengyuan Pharmaceutical, Arromax Pharmaceutical Technology, Lihe Wuhan New Chemical Materials, Shandong Anxin Pharmaceutical, Zhejiang Tianyu Pharmaceutical, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Montelukast Sodium. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Montelukast Sodium market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Montelukast Sodium market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Montelukast Sodium industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Montelukast Sodium Include:

Morepen Laboratories

Mylan

TAPI

MSN Laboratories

Ultratech India

Aurobindo Pharma

Hetero Labs

Unimark Remedies

Jubilant Cadista

Aamorb Pharmaceuticals

Sudarshan Group

Ortin Laboratories

Adley Group

Vamsi Labs

Medopharm

Hengyuan Pharmaceutical

Arromax Pharmaceutical Technology

Lihe Wuhan New Chemical Materials

Shandong Anxin Pharmaceutical

Zhejiang Tianyu Pharmaceutical

Montelukast Sodium Product Segment Include:

Montelukast Sodium Amorphous

Montelukast Sodium Crystalline

Montelukast Sodium Product Application Include:

Tablets

Chewable Tablet

Oral Solution


Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Montelukast Sodium Industry PESTEL Analysis

Chapter 3: Global Montelukast Sodium Industry Porter’s Five Forces Analysis

Chapter 4: Global Montelukast Sodium Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Montelukast Sodium Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Montelukast Sodium Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Montelukast Sodium Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Montelukast Sodium Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Montelukast Sodium Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Montelukast Sodium Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Montelukast Sodium Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Montelukast Sodium Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources


Competitor Data

Global Montelukast Sodium Revenue, Sales and Market Share by Player

Revenue (US$ Million)20202021202220232024
Morepen LaboratoriesXXXXXXXXXX
MylanXXXXXXXXXX
TAPIXXXXXXXXXX
MSN LaboratoriesXXXXXXXXXX
Ultratech IndiaXXXXXXXXXX
Aurobindo PharmaXXXXXXXXXX
Hetero LabsXXXXXXXXXX
Unimark RemediesXXXXXXXXXX
Jubilant CadistaXXXXXXXXXX
Aamorb PharmaceuticalsXXXXXXXXXX
Sudarshan GroupXXXXXXXXXX
Ortin LaboratoriesXXXXXXXXXX
Adley GroupXXXXXXXXXX
Vamsi LabsXXXXXXXXXX
MedopharmXXXXXXXXXX
Hengyuan PharmaceuticalXXXXXXXXXX
Arromax Pharmaceutical TechnologyXXXXXXXXXX
Lihe Wuhan New Chemical MaterialsXXXXXXXXXX
Shandong Anxin PharmaceuticalXXXXXXXXXX
Zhejiang Tianyu PharmaceuticalXXXXXXXXXX
Other CompaniesXXXXXXXXXX
TotalXXXXXXXXXX


image.png


Sales (K Unit)20202021202220232024
Morepen LaboratoriesXXXXXXXXXX
MylanXXXXXXXXXX
TAPIXXXXXXXXXX
MSN LaboratoriesXXXXXXXXXX
Ultratech IndiaXXXXXXXXXX
Aurobindo PharmaXXXXXXXXXX
Hetero LabsXXXXXXXXXX
Unimark RemediesXXXXXXXXXX
Jubilant CadistaXXXXXXXXXX
Aamorb PharmaceuticalsXXXXXXXXXX
Sudarshan GroupXXXXXXXXXX
Ortin LaboratoriesXXXXXXXXXX
Adley GroupXXXXXXXXXX
Vamsi LabsXXXXXXXXXX
MedopharmXXXXXXXXXX
Hengyuan PharmaceuticalXXXXXXXXXX
Arromax Pharmaceutical TechnologyXXXXXXXXXX
Lihe Wuhan New Chemical MaterialsXXXXXXXXXX
Shandong Anxin PharmaceuticalXXXXXXXXXX
Zhejiang Tianyu PharmaceuticalXXXXXXXXXX
Other CompaniesXXXXXXXXXX
TotalXXXXXXXXXX


image.png


Order Process

Contact

1. Fill in your contact information, and the company will quickly match the specialist to get in touch with you

2. You can also directly call our customer service hotline or add customer service WeChat

Samples

1. One on one business specialist will send the complete version of the sample

2. If you need to customize the report, professional analysts will be arranged to communicate with you one-on-one and provide you with customized samples

Payment

1. Both parties sign a report purchase contract

2. Support Paypal, Visa, UnionPay and MasterCard Payment

Delivery

1. PDF report (sent online 2-3 working days after payment)

2. WORD version report (sent online 2-3 working days after payment)

3. Paper version report (sent via EMS or DHL within 3-5 working days after payment)

After-Sales

Within six months of purchasing the report, if you have any questions about the details of our report, you can contact the report analyst at any time. The analyst will continue to follow up and solve your problem until you are satisfied

Didn't find the report you wanted? Please contact us!